SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZN, AMYT, CINC

NEW YORK, Jan. 15, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Horizon Global Corporation (: HZN)’s sale to First Brands Group, LLC for $1.75 per share. If you are a Horizon Global shareholder, click here to learn more about your legal rights and options.

Amryt Pharma Plc ( AMYT)’s sale to Chiesi Farmaceutici S.p.A. Per the terms of the proposed transaction, Chiesi would acquire Amryt for $14.50 in cash per American Depositary Share (ADS) of Amryt plus Contingent Value Rights of up to $2.50 per ADS payable if certain milestones related to Amryt’s product Filsuvez® are achieved. If you are an Amryt shareholder, click here to learn more about your rights and options.

CinCor Pharma, Inc. ( CINC)’s sale to AstraZeneca for $26.00 per share in cash at closing, plus a non-tradable contingent value right of $10.00 per share in cash payable upon a specified regulatory submission of a baxdrostat product. If you are a CinCor shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

ti?nf=ODcyOTk5OSM1MzU2MzMyIzIxMjU4MTU=
Halper-Sadeh-LLC.png